Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Faivre S; Delbaldo C; Vera K; Robert C; Lozahic S; Lassau N; Bello C; Deprimo S; Brega N; Massimini G

doi:10.1200/jco.2005.02.2194

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Identifier:nobleid.org/w1/20260526/5704AF01

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5704AF01.svg?ark=w1%2F20260526%2F5704AF01)](https://nobleid.org/work/w1/20260526/5704AF01)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Identifier:nobleid.org/w1/20260526/5704AF01

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5704AF01.svg?ark=w1%2F20260526%2F5704AF01)](https://nobleid.org/work/w1/20260526/5704AF01)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work